Science Explorer Back to mapMap
Discussion
Researcher · Cyclacel Pharmaceuticals (United Kingdom) · United Kingdom

David G. BLAKE

David G. BLAKE publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Cancer-related Molecular Pathways, Advanced Breast Cancer Therapies and Chronic Lymphocytic Leukemia Research.

ORCID 0000-0002-8367-3256 OpenAlex
World rank
#2,053,100
of 7,710,434 ranked researchers
Rank in United Kingdom
#150,223
of 367,258
Works
52
Citations
1.3k
Citations per work
24.4
h-index
16
i10-index 20Top 33% in Oncology
David G. BLAKE

What does David G. BLAKE research?

David G. BLAKE's work is mostly in Medicine (45%), Biochemistry, Genetics and Molecular Biology (22%).

Health Sciences: 23 works · 44.9% of their workMedicine: 23 works · 44.9% of their workOncology: 12 works · 23.2% of their workPulmonary and Respiratory Medicine: 6 works · 11.6% of their workGenetics: 3 works · 6.5% of their workHematology: 2 works · 3.6% of their workEverything else: 17 works · 33.3% of their workLife Sciences: 11 works · 21.8% of their workBiochemistry, Genetics and Molecular Biology: 11 works · 21.8% of their workMolecular Biology: 9 works · 16.7% of their workCell Biology: 3 works · 5.1% of their workTHEIR WORKDavid G. BLAKE52works
Life Sciences22%Health Sciences45%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2344.9%
  2. Everything else1733.3%
    1. Biochemistry, Genetics and Molecular Biology1121.8%
  1. 1Oncology23% of their works
  2. 2Molecular Biology17% of their works
  3. 3Pulmonary and Respiratory Medicine12% of their works
  4. 4Genetics6% of their works
  5. 5Cell Biology5% of their works
  6. 6Hematology4% of their works

Research topics

Which keywords describe David G. BLAKE's research?

The keywords of their largest research topics: Cancer Therapy, Cell Cycle, p53, Breast Cancer, CDK4/6 Inhibitors, Homologous Recombination, Chronic Lymphocytic Leukemia and Genomic Aberrations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer Therapy313 topics
  2. Cell Cycle191 topic
  3. p53191 topic
  4. Breast Cancer131 topic
  5. CDK4/6 Inhibitors131 topic
  6. Homologous Recombination102 topics
  7. Chronic Lymphocytic Leukemia91 topic
  8. Genomic Aberrations91 topic
  9. BRCA Mutation61 topic
  10. Cell Division61 topic
  11. Microtubules61 topic
  12. PARP Inhibitors61 topic
  13. BET Bromodomains51 topic
  14. PROTACs51 topic
  15. DNA Damage41 topic
  16. Glutathione41 topic
  17. Hydrogen Sulfide41 topic
  18. Repair41 topic

Where does David G. BLAKE work?

David G. BLAKE's main affiliation in the publication record is Cyclacel Pharmaceuticals (United Kingdom), United Kingdom.

How many publications and citations does David G. BLAKE have?

OpenAlex counts 52 works and 1,267 citations for David G. BLAKE, an h-index of 16, ranking #2,053,100 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about David G. BLAKE. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.